Fortress Biotech

FBIO NASDAQ
1.600
+0.070
+4.58%
After Hours: 1.600 0 0.00% 17:00 08/16 EDT
Open
1.560
Prev Close
1.530
High
1.670
Low
1.525
Volume
160.10K
Avg Vol (3M)
368.65K
52 Week High
2.590
52 Week Low
0.4900
% Turnover
0.23%
Market Cap
110.47M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Fortress Biotech FBIO stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Fortress Biotech, Inc.(Fortress) is a biopharmaceutical company that acquires, develops and commercializes novel pharmaceutical and biotechnology products. Fortress develops and commercializes products both within Fortress and through certain of its subsidiary companies. Fortress has 11 operating subsidiaries that include: 4 commercial stage programs, 25 development stage programs, targeting 6 therapeutic areas: Immuno-oncology, Hematology, Gene Therapy, Pain Management, Rare Diseases and Dermatology. In addition to its internal development programs, Fortress leverages its biopharmaceutical business expertise and drug development capabilities and provides funding and management services to help the Fortress Companies. Fortress subsidiaries include Aevitas Therapeutics, Avenue Therapeutics, Caelum Biosciences, Cellvation, Inc., Checkpoint Therapeutics, Cyprium Therapeutics, Helocyte, Inc., Journey Medical Corporation, Mustang Bio and Tamid Bio, Inc.
MORE >

Recently

Name
Price
%Change